Ligand Pharmaceuticals (LGND) EPS (Diluted) (2010 - 2026)
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EPS (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 0.15 |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 10 | Ligand Pharmaceuticals | 5.76 Bn | 4.40 Bn | 60.48 Mn | 2.22 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22 |
| Mar 31, 2026 | -0.67 |
| Dec 31, 2025 | 2.21 |
| Sep 30, 2025 | 5.68 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | -2.21 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -2.88 |
| Mar 31, 2024 | 4.75 |
| Dec 31, 2023 | 1.02 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 2.33 |
| Dec 31, 2022 | -1.04 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.91 |
| Dec 31, 2021 | 0.67 |
| Sep 30, 2021 | 0.41 |